U
Ulrich Bogdahn
Researcher at University of Regensburg
Publications - 347
Citations - 36060
Ulrich Bogdahn is an academic researcher from University of Regensburg. The author has contributed to research in topics: Neural stem cell & Neurogenesis. The author has an hindex of 67, co-authored 344 publications receiving 32279 citations. Previous affiliations of Ulrich Bogdahn include Hoffmann-La Roche & Volkswagen Foundation.
Papers
More filters
Journal ArticleDOI
Transcranial ultrasound from diagnosis to early stroke treatment. 1. Feasibility of prehospital cerebrovascular assessment.
Thilo Hölscher,Felix Schlachetzki,Markus Zimmermann,Wolfgang Jakob,Karl Peter Ittner,Johann Haslberger,Ulrich Bogdahn,Sandra Boy +7 more
TL;DR: Emergency assessment of intracranial arteries using portable duplex ultrasound devices is feasible shortly after arrival at the patient’s site.
Journal ArticleDOI
Vascularization of primary central nervous system tumors: detection with contrast-enhanced transcranial color-coded real-time sonography.
Ulrich Bogdahn,T Fröhlich,Georg Becker,A. Krone,R Schlief,J Schürmann,Piotr Jachimczak,Erich Hofmann,W Roggendorf,Klaus Roosen +9 more
TL;DR: In this paper, the potential of contrast material-enhanced transcranial color-coded real-time sonography (TCCS) in detection of primary intracranial tumor vascularization was studied.
Journal ArticleDOI
The Granulocyte-colony stimulating factor has a dual role in neuronal and vascular plasticity.
Stephanie Wallner,Sebastian Peters,Claudia Pitzer,Herbert Resch,Ulrich Bogdahn,Armin Schneider +5 more
TL;DR: This work reviews and discusses these dual properties of G-CSF, and discusses the neuroregenerative potential of this growth factor in view of the plasticity of the vasculature.
Journal ArticleDOI
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial
Albert C. Ludolph,Joachim Schuster,Johannes Dorst,Luc Dupuis,Jens Dreyhaupt,Jochen H. Weishaupt,Jan Kassubek,Ulrike Weiland,Susanne Petri,Thomas Meyer,Julian Grosskreutz,Berthold Schrank,Matthias Boentert,Alexander Emmer,Andreas Hermann,Daniel Zeller,Johannes Prudlo,Andrea Sylvia Winkler,Torsten Grehl,Michael T. Heneka,Siw Johannesen,Bettina Göricke,Andreas Funke,Dagmar Kettemann,Robert Meyer,Kai Gruhn,Peter Schwenkreis,Philipp Stude,MichaelT Heneka,Delia Kurzwelly,Alexander Storch,Nicole Richter,Tobias Frank,Katharina Hein,Frank Hanisch,Dagmar Hanke,Torsten Kraya,Andreas Posa,Martina Romanakova,Susanne Schilling,Susanne Abdulla,Sebastian Böselt,Claas Janssen,Imken Lange,Xenia Kobeleva,Sonja Körner,Katja Kollewe,Alma Osmanovic,Nicole Scharn,Klaus J Rath,Christiane Dahms,A. Gunkel,Bianka Heiling,Thomas M. Ringer,Uta Smesny,Sarah Baumeister,Achim Berthele,Sarah Bublitz,Esra Akova-Öztürk,Bianca Stubbe-Dräger,Alexandra Rahmann,Charlotte Young,Peter Young,Dobri Baldaranov,Ulrich Bogdahn,Andrei Khomenko,Wilhelm Schulte-Mattler,Christina Stadler,Susanne Husung,Simone Tesar,Nigar Dargah-Zaden,Eva Langer,Ann-Sophie Lauenstein,Eckard Lensch,Carolyn Mc Farlane,Heike Fischer-Brasse,Klara Orbán,Bertold Schrank,Sonja Schürger,Stephan Klebe,Peter Kraft,Thomas Musacchio,Carola Seiler +82 more
TL;DR: There was no difference between groups in the primary outcome of survival, although post-hoc analysis suggested that rasagiline might modify disease progression in patients with an initial slope of Amyotrophic Lateral Sclerosis Functional Rating Scale Revised greater than 0·5 points per month at baseline.
Journal ArticleDOI
Autologous adult rodent neural progenitor cell transplantation represents a feasible strategy to promote structural repair in the chronically injured spinal cord
Katharina Pfeifer,Maurice Vroemen,Massimiliano Caioni,Ludwig Aigner,Ulrich Bogdahn,Norbert Weidner +5 more
TL;DR: These findings demonstrate that the therapeutic strategy to induce structural repair by transplanting adult autologous NPCs, after the successful propagation from a small brain biopsy into an acute CNS disease model, such as spinal cord injury, is feasible at the preclinical level.